COMMUNIQUÉS West-GlobeNewswire

EDAP TMS SA : EDAP to Showcase Suite of Therapeutic Ultrasound Products During the American Urology Association Annual Meeting
29/04/2019
EDAP to Provide Live Demonstrations and Host Q&A with Interested Parties at Booth #2211 LYON, France, April 29, 2019 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it [...]
MediPharm Labs Appoints Former Johnson & Johnson Group Product Director as Chief Strategy Officer
29/04/2019
New Pharma Executive Position Created to Advance Corporate Strategy, Global Growth and Strategic Partnerships TORONTO, April 29, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“ [...]
Hendrick Health System selects Allscripts to provide single patient record, billing and database solution
29/04/2019
Health system signs strategic agreement to deploy suite of solutions including Allscripts Sunrise™ Ambulatory EHR, Sunrise™ Financial Manager, Sunrise™ Health Information Manager, FollowMyHealth® and Allscripts Patient [...]
Foamix to Present Late Breaking Data at the 77th Annual Meeting of the Society for Investigative Dermatology
29/04/2019
REHOVOT, Israel and BRIDGEWATER, N.J., April 29, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a clinical stage specialty pharmaceutical company focused on developing [...]
Teneobio Announces US FDA Approval of the Investigational New Drug Application for TNB-383B and the Initiation of Phase I Clinical Studies in Multiple Myeloma Patients
29/04/2019
NEWARK, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Teneobio, Inc. and its affiliate TeneoOne, Inc. announced today that their investigational new drug application (IND) for TNB-383B, a bispecific T-cell engaging [...]
Krystal Biotech Announces Five Presentations of Clinical and Preclinical Data at the Society for Investigative Dermatology Annual Meeting
29/04/2019
PITTSBURGH, April 29, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company developing medicines to treat rare skin diseases announces presentations of clinical data for [...]
Avadel Pharmaceuticals Announces Appointment of Jordan Dubow, M.D., as Chief Medical Officer
29/04/2019
DUBLIN, Ireland, April 29, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218 for sleep disorders, today announced that it has appointed Jordan Dubow, M.D., as [...]
Evolus to Participate in Two Upcoming Investor Conferences
29/04/2019
IRVINE, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that members of [...]
PetMed Express D/B/A 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 6, 2019
29/04/2019
DELRAY BEACH, Fla., April 29, 2019 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for the fiscal year ended March 31, 2019 on Monday, May 6, 2019 at 8:00 A.M. Eastern Time, [...]
Soleno Therapeutics Announces Appointment of Industry Veteran Gwen A. Melincoff to Board of Directors
29/04/2019
REDWOOD CITY, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
Progressive Care, Inc CEO Recognized by Forbes as a Unique Leader
29/04/2019
MIAMI, April 29, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered media coverage in Forbes in an article [...]
Scott Shuda Appointed to IRIDEX Board of Directors
29/04/2019
MOUNTAIN VIEW, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced [...]
Extendicare Announces Timing of 2019 First Quarter Results and Conference Call
29/04/2019
MARKHAM, Ontario, April 29, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first quarter of 2019, after [...]
LogicBio Therapeutics Receives FDA Orphan Drug Designation for LB-001 for the Treatment of Methylmalonic Acidemia
29/04/2019
CAMBRIDGE, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, today [...]
Medovex Corporation Announces Recent Management Appointments
29/04/2019
Highly Experienced Team Responsible for Building a Previous $250M Plus Revenue Health Care Enterprise Reunited Under CEO Bill Horne ALPHARETTA, Ga., April 29, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX [...]
ChemioCare Announces Appointment of Roy F. Waldron to Its Board of Directors
29/04/2019
NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company focused on proprietary transdermal delivery, announced today the appointment of Roy F. Waldron to its [...]
Aleafia Health Reports 2018 Fiscal Year-end Results, Provides Corporate Update
29/04/2019
Aleafia & Emblem Y/Y Pro-forma Revenue Increases 327% to $11.5M Buildout of Three Production Facilities Nearing Completion Anticipated Annual Cannabis Cultivation & Extraction Capacity to Reach 138,000 kg, 50, [...]
Immunomedics and Everest Medicines Announce Exclusive License Agreement for Sacituzumab Govitecan in East and Southeast Asia Excluding Japan
29/04/2019
The Largest Single-Asset License Agreement for Greater China To Date Provides Everest Medicines the Right to Develop and Commercialize Sacituzumab Govitecan for All Cancer Indications in Greater China, South Korea, and [...]
Immunomedics Announces Departure of Chief Medical Officer
29/04/2019
MORRIS PLAINS, N.J., April 29, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]

Pages